Multidrug resistance

Tuberculosis mortality and drug resistance among patients under TB treatment before and during COVID-19 in Burundi: a case–control study | BMC Infectious Diseases

by

World Health Organization. Global tuberculosis report 2024. Geneva: WHO; 2024. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024. World Health Organization. WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/ rifampicin-resistant TB (MDR/RR-TB), 2021–2025: background document. Geneva. World Health Organization (https://apps.who.int/iris/handle/10665/341980). Thornton J. Don’t forget chronic lung and immune conditions during covid-19, says WHO. In.: British … Read more

Regional insights on the prevalence and antimicrobial susceptibility pattern of carbapenem and colistin-resistant gram-negative bacteria: an observational cross-sectional study from Karachi, Pakistan | BMC Infectious Diseases

by

Study setting and design This observational, cross-sectional study was conducted at the Microbiology laboratory of Indus Hospital & Health Network in Karachi, Pakistan from January 1, 2022 to December 31, 2023. Indus Hospital & Health Network is one of the largest non-profit networks of primary, secondary and tertiary healthcare facilities across Pakistan. As part of … Read more